Rare diseases
Investigational molecules
Locations
Study on the Effects of Adalimumab, Vedolizumab, and Tofacitinib on Heart Health in Patients with Ulcerative Colitis
FranceStudy on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer
FranceStudy on the Effectiveness and Safety of CT-P13 for Patients with Moderate to Severe Rheumatoid Arthritis
PolandStudy of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
AustriaStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
AustriaStudy on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer
BelgiumStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
AustriaStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
BelgiumStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
AustriaStudy on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
AustriaStudy on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases
FranceStudy on the Effects of Tofacitinib and Drug Combination on Blood Clotting in Patients with Ulcerative Colitis
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
